Pioneering Study in Parkinson's Disease to Advance Surgical Treatment Options RebrAIn, a leader in precise targeting solutions for deep brain stimulation (DBS) and lesion techniques, today announced ...

RebrAIn, specialized in precise targeting solutions for DBS treatments and lesion techniques, completed the recruitment of ...

TORONTO, ON, Oct. 1, 2024 /PRNewswire-PRWeb/ -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech and medical device industries. Access to all ...

In this free webinar, learn how real-world data (RWD) can streamline patient recruitment, enhance diversity and support compliance with the US Food and Drug Administration (FDA) guidelines for running ...

The NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III ...

Spiritual beliefs and a historically-based distrust of clinical research may factor into Black patients' decisions about whether to participate in cancer trials, according to surveys of patients ...

After a six-month beta testing period, the European Clinical Trials Information Network is rolling out its patient ...

Spiritual beliefs and a historically-based distrust of clinical research may factor into Black patients' decisions about ...

Spiritual beliefs and a historically-based distrust of clinical research may factor into Black patients' decisions ...

Clinical trial recruitment stands at the forefront of drug and medical device development for companies, yet it often ...

Researchers at Fred Hutch Cancer Center identified a substantial increase over the past decade in the proportion of patients with cancer in the U.S. who participate in pharmaceutical industry ...

Phase 3 ENLIGHTED study enrollment completion expected by first quarter of 2025TEL AVIV, Israel, Sept. 27, 2024 (GLOBE ...